|
COPD with osteoporosis,(n)
|
COPD without osteoporosis,(n)
|
Total
|
Adjusted OR (95% CI)
|
adjusted p value
|
TNF α≥ 2,47 pg/ml
|
29
|
10
|
39
|
2,82-8,78
|
0,01
|
TNFα< 2,47 pg/ml
|
6
|
25
|
31
|
IL-1B ≥ 0,76 pg/ml
IL-1B < 0,76 pg/ml
|
27
8
|
25
10
|
52
18
|
0,11-6,07
|
0,11
|
IL-6 ≥ 0,74 pg/ml
Il-6 < 0,74 pg/ml
|
29
6
|
8
27
|
37
33
|
2,11-8,57
|
0,00
|
IL-17 ≥ 1,8 pg/ml
IL-17 < 1,8 pg/ml
|
25
10
|
8
27
|
33
37
|
2,17-9,58
|
0,02
|
RANKL ≥ 111,2 ng/ml
RANKL < 111,2 ng/ml
|
27
8
|
23
12
|
50
20
|
0,18-3,43
|
0,12
|
OPG ≥ 4,0 ng/ml
OPG < 4,0 ng/ml
|
34
1
|
30
5
|
64
6
|
0,02-1,58
|
0,88
|
CTx ≥ 0,4 ng/ml
CTx < 0,4 ng/ml
|
30
5
|
5
30
|
35
35
|
2,62-13,66
|
0,00
|